Experimental RNA therapy targets returning bone cancer in single patient
NCT ID NCT07560709
First seen May 02, 2026 · Last updated May 02, 2026
Summary
This study provided a single patient with recurrent osteosarcoma (a type of bone cancer) access to an experimental treatment made from their own tumor's genetic material. The treatment, called RNA-loaded lipid particles (RNA-LPs), was designed to help the immune system fight the cancer. The patient had already tried a similar treatment and their disease had worsened before receiving this personalized version.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OSTEOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida Health
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.